Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Aug 18, 2011

Premium

Addex Pharmaceuticals, a developer of allosteric modulators, has named Bharat Chowrira as its CEO.

Chowrira previously served as senior vice president and COO of Nektar Therapeutics. Before that, he was executive director of worldwide licensing and external research at Merck. He joined Merck after the company acquired Sirna Therapeutics, where Chowrira was vice president of legal affairs and patent counsel.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.